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Abstract
p23 is a small acidic protein with intrinsic molecular chaperone activity. It is best known as a
co-chaperone of the major cytosolic molecular chaperone Hsp90. p23 binds the N-terminus
of Hsp90 and stabilizes the ATP-bound and N-terminally closed Hsp90 dimer. It is in this
configuration that many Hsp90 clients are most stably bound. Considering the important
role of p23 in the Hsp90 cycle, it came as a surprise that it is not absolutely essential for via-
bility in the budding yeast or for mouse development. Mice without p23 develop quite nor-
mally until birth and then all die perinatally because of immature lungs. The only other
apparent phenotype of late stage embryos and newborns is a skin defect, which we have
further characterized here. We found that skin differentiation is impaired, and that both apo-
ptosis and cell proliferation are augmented in the absence of p23; the consequences are a
severe thinning of the stratum corneum and reduced numbers of hair follicles. The altered
differentiation, spontaneous apoptosis and proliferation are all mimicked by isolated primary
keratinocytes indicating that they do require p23 functions in a cell-autonomous fashion.
Since the phenotype of p23-null embryos is strikingly similar to that of embryos lacking the
glucocorticoid receptor, a paradigmatic Hsp90-p23 client protein, we investigated glucocorti-
coid signaling. We discovered that it is impaired in vivo and for some aspects in isolated ker-
atinocytes. Our results suggest that part of the phenotype of p23-null embryos can be
explained by an impact on this particular Hsp90 client, but do not exclude that p23 by itself
or in association with Hsp90 affects skin development and homeostasis through yet other
pathways.
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Introduction
p23, whose official name is Ptges3 for rather arcane historical reasons, is a small, acidic protein
that was initially discovered as an essential component of the Hsp90 chaperone machinery
required for correct assembly of steroid receptor complexes [1,2]. Since then many other
Hsp90 clients were found to rely on the contribution of p23 as an Hsp90 co-chaperone (for
comprehensive overview, see https://www.picard.ch/downloads/p23facts.pdf). The direct
binding of p23 to the N-terminal domain of Hsp90 is ATP-dependent [3,1] and results from
the ATP-induced N-terminal dimerization of Hsp90 [4,5]. p23 inhibits both the basal and sub-
strate-stimulated ATPase activity of Hsp90 resulting in the stabilization of the nucleotide-
bound closed state of Hsp90 [6–8]. Apart from being an important regulator of the Hsp90
chaperoning cycle [9,8], p23 has its own Hsp90-independent chaperone activity, which can
prevent protein aggregation and maintain proteins in a folding-competent state [10–12]. At
the cellular level, p23 is mostly cytoplasmic, but can also be found in the nucleus [13–15]. In
the nucleus, in addition to acting as a co-chaperone for Hsp90 present in the nucleus p23
deploys its chaperone activity to promote the dynamic binding and dissociation of DNA- and
chromatin-binding complexes [16–19].
The Hsp90 co-chaperone p23 is found in almost all eukaryotes [20]. In the mouse, it is ubiq-
uitously expressed with the exception of striated muscle, where it is replaced by the related co-
chaperone Aarsd1 [16,21]. The crucial role of p23 in the mouse has been demonstrated by our
group [22] and others [23,24]. p23 gene disruption mice die at birth, most likely because of the
immaturity of their lungs; in addition, late stage embryos and newborns display a significant
underdevelopment of the skin; notably, the stratum corneum is much thinner and the skin
barrier function is defective [22]. The tissue selectivity of this phenotype was surprising in
view of the expected house-keeping functions of p23 and Hsp90. The phenotype is strikingly
reminiscent of what has been reported for the knockout of the gene for the glucocorticoid
receptor (GR) [25–28], a paradigmatic Hsp90 client protein (reviewed in refs. [29,30]). GR is
an important regulator of skin development and homeostasis and responds to both systemic
sources of glucocorticoids and glucocorticoids produced locally from cholesterol in the skin
itself [31–34]. Upon first describing the skin phenotype [22], we therefore explored the con-
nection with GR. We found that mouse embryonic fibroblasts derived from p23 null embryos
showed abnormalities in GR functions: although they could still respond to glucocorticoids, it
took longer or higher glucocorticoid concentrations [22]. The findings both with the lung and
the skin were compatible with the speculation that GR may be the main p23 target, at least dur-
ing the late stages of embryonic development.
While the skin phenotype of GR mutant mice has been extensively studied [26–28,35,36],
our own characterization of the skin phenotype of p23 null mice had been relatively limited
and no additional study has been reported since then. Here we have revisited the skin pheno-
type of p23 null mice in more detail and further investigated the p23-GR connection.
Results
Effects on proliferation, differentiation, and apoptosis in the skin
We and others had previously reported the importance of p23 for the correct development of
whole body skin in the mouse [22–24]. While these studies had provided a first characteriza-
tion of the skin phenotype, a more in-depth description is needed to suggest underlying
molecular defects. We set out to fill this gap by analyzing the skin of p23-/- E18.5 embryos.
Upon dissection, the skin devoid of p23 was found to be clearly thinner. As illustrated in Fig
1A with the sections stained with haematoxylin and eosin (H&E) and confirming our earlier
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Fig 1. Lack of p23 results in decreased epidermal thickness, delayed differentiation and increased
rates of proliferation and apoptosis in E18.5 skin. (a) Representative sections stained with H&E showing
epidermal skin (delimited by red line) thinning with almost absent stratum corneum in embryonic p23-/- skin
sections along with lower numbers of hair follicles. E, epidermis; HF, hair follicle; SC, stratum corneum. (b)
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observations [22], the outermost layer of the skin, the stratum corneum, is strikingly reduced.
This is corroborated by the morphometric analysis (Fig 1B). In addition, the number of hair
follicles in p23-/- compared to wild-type skin is significantly reduced (Fig 1A and 1C). Further-
more, the immunohistochemical analysis of several markers of skin differentiation (loricrin,
filaggrin and involucrin) showed reduced levels of these proteins in p23-/- skin (Fig 1D), indi-
cating that the differentiation process is perturbed in embryonic skin in the absence of p23.
Skin thinning could be partially due to a reduced number of cells, either because of increased
apoptosis or altered proliferation or some combination of both. In fact, p23 has previously
been linked to caspase activation and apoptosis. p23 can be C-terminally truncated by caspases
3, 7 and 8, and this is enhanced by geldanamycin [37], and it was reported that p23 cleavage
and degradation can be induced by apoptotic stimuli [38]; the effects if the proposed p23
inhibitor gedunin are enhanced by caspase 7 cleavage of p23 [39]. In light of these findings, we
decided to check the extent of spontaneous apoptosis in p23-/- skin. As shown in Fig 1E,
TUNEL staining in p23-/- versus wild-type skin revealed that there is a significant increase in
the number of apoptotic cells in p23-/- skin. Proliferation is affected as well, albeit not as one
might have expected based on the dramatically reduced skin thickness: in vivo BrdU staining
revealed a significantly increased proliferation rate in p23-/- skin (Fig 1F), which may be sub-
stantially counterbalanced by the dramatically increased apoptosis.
Absence of p23 phenocopies some defects of GR-deficient skin
In order to define the types of skin cells where p23 might act, we determined the pattern of
p23 protein expression in mouse embryonic skin by immunohistochemical staining (Fig 2A;
top panel). This revealed expression of p23 in hair follicles, basal keratinocytes, some cells of
the stratum spinosum and stratum granulosum and also cells of the dermis. Considering the
role of p23 as an Hsp90 co-chaperone and the striking parallels of the phenotype of the p23-/-
mouse with the phenotype of the mouse lacking the Hsp90 client GR, we wanted to clarify if
the lack of p23 has an effect on the levels of GR in embryonic skin. As can be seen in the immu-
nohistochemical analysis of Fig 2A (middle panel) and the immunoblot of Fig 2B, the levels of
GR protein do not unambiguously correlate with a specific genotype. This result is in agree-
ment with our previous findings with mouse embryonic fibroblasts, in which levels of GR also
did not always correlate with the presence or absence of p23 [22]. Overall, GR levels neverthe-
less appear to be reduced in the absence of p23. Next, we reasoned that GR function may be
compromised despite the lack of a clear effect on GR levels. We therefore assessed the expres-
sion of a direct GR target gene, Fkbp51, at the protein level. In this case, we found significantly
lower levels of Fkbp51 in histological sections and by immunoblotting in p23-/- E18.5 skin (Fig
2A and 2B). We used qPCR to look at several other GR targets in the skin and noticed signifi-
cant differences in the mRNA levels of several genes whose expression had previously been
linked to perturbed GR function in the skin (Fig 2C) [27,36]. The mRNAs for defensin β-1
(Defb1), which is related to the innate immune response and epithelial defense, and corneodes-
mosin (Cdsn), associated with the later stages of epidermal differentiation, are significantly
downregulated; the mRNA for E74-like factor 5 (Elf5) and keratin-77 (Krt77), both normally
Quantitation of epidermal thickness and (c) number of hair follicle per 100 μm basal membrane (BM) in p23-/-
and wild-type E18.5 skin sections; significant decrease of epidermal thickness (*** p<0.001) and hair follicle
numbers (** p<0.01) in p23-/- skin (n: WT = 4, p23-/- = 3). (d) Immunohistochemical staining for the
differentiation markers loricrin, filaggrin and involucrin shows decrease in staining intensity in p23-/- E18.5 skin
sections. (e) TUNEL assay indicates significantly higher apoptotic rate in p23-/- E18.5 skin sections compared
to wild-type (*** p<0.001; n: WT = 4, p23-/- = 4). (f) BrdU staining of nuclei indicates increased proliferation in
p23-/- skin sections (** p<0.01; n: WT = 7, p23-/- = 7). Black bars in panels a and d indicate 50 μm.
https://doi.org/10.1371/journal.pone.0180035.g001
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Fig 2. Expression of p23, GR, Fkbp51 and other GR target genes in E18.5 skin. (a) Immunohistochemical staining for
p23, GR, and Fkbp51 in E18.5 skin sections. Note that GR staining was detected almost exclusively in basal keratinocytes,
with very few positive cells in the suprabasal layers, and that GR is also present in the dermal compartment. Fkb51 levels were
markedly lower in the epidermis of p23-/- E18.5 embryos, while expression of GR was slightly lower in some but not all p23-/-
skin sections compared to wild-type. For each protein and genotype, sections of two different embryos are shown. White bars
indicate 50 μm. (b) Representative immunoblot (top panel) of extracts from 4 WT and 3 p23-/- embryos shows reduced GR
protein levels in E18.5 epidermis in some but not all p23-/- E18.5 epidermal samples compared to wild-type. The quantitation of
two immunoblots with a total of 6 WT and 7 p23-/- samples is shown as a bar graph. A trend to a reduction of GR levels is
suggested by the statistical analysis (p = 0.0566), whereas Fkbp51 levels are undoubtedly decreased in p23-/- E18.5
epidermis (*** p<0.001). Immunoblotting for p23 was used to confirm the genotype and GAPDH served as loading control. (c)
Relative mRNA levels of several other GR target genes in p23-/- vs. wild-type E18.5 epidermis, quantified by qPCR. Results
are representative of three independent experiments, each with the 6 WT and 7 p23-/- samples.
https://doi.org/10.1371/journal.pone.0180035.g002
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induced earlier during epidermal development, are upregulated. Thus, the effects in E18.5
p23-/- skin samples were similar to what had been observed for GR-/- skin.
Effects of p23 on keratinocytes are cell-autonomous
In order to find out whether the above-mentioned abnormalities in proliferation, differentia-
tion and apoptosis in p23-/- skin indicate cell-autonomous requirements for p23, we decided to
isolate mouse primary epidermal keratinocytes (MPKs) for in vitro analyses. Due to the fact
that embryonic skin without p23 is significantly thinner than that of the wild-type, we expected
to obtain lower yields of isolated MPKs from individual E18.5 embryos, which was indeed the
case as can be seen in Fig 3A and 3B. Note that since the isolation of MPKs can be technically
quite challenging, we isolated MPKs from wild-type and p23-/- embryos in parallel and based
our analysis on a rather large number of embryos. Moreover, since the BrdU staining had
revealed hyperproliferation in p23-/- skin samples, we compared cell numbers of wild-type and
p23-/- MPKs at 24, 72 and 120 h after seeding the exact same number of cells; we found that
there were significantly more p23-/- than wild-type MPKs at the 120 h time point (Fig 3C).
Interestingly, this is reminiscent of the observation that GR-/- keratinocytes display a hyperpro-
liferative phenotype [26]. Furthermore, we wanted to confirm whether the phenotype of
increased apoptosis in p23-/- skin was also recapitulated with p23-/- MPKs in vitro. For this pur-
pose, we measured annexin V staining by flow cytometry without and with prior UV treat-
ment of the cells; MPKs without p23 proved to have increased spontaneous as well as UV-
induced apoptosis (Fig 3D and 3E).
Keratinocyte differentiation can be induced in vitro by adding calcium [40]. We used this
treatment to assess the ability of p23-/- MPKs to differentiate. As can be seen in Fig 4A, p23-/-
cells did not show any obvious morphological differences relative to wild-type 24 h or even 48
h after addition of 1.2 mM Ca2+. To investigate this in more detail, we performed immunoflu-
orescence staining for markers of early (keratin-10 and E-cadherin) and late (involucrin) dif-
ferentiation (Fig 4B). We found that p23-/- MPKs show decreased levels of staining for all
three, indicating that even though MPKs are able to differentiate in the absence of p23, differ-
entiation is impaired. The reduced E-cadherin expression is likely to have a negative impact
on cell-cell contacts and on the integrity of the epithelial barrier function, consistent with our
original findings with whole embryos [22].
Some effects of glucocorticoids on MPKs are influenced by the p23
status
Considering the connections between p23 and GR, we set out to investigate the influence of
p23 on the response of isolated MPKs to glucocorticoids. The activation of GR can be moni-
tored by assessing its hormone-induced nuclear localization [41]. To investigate the Dex-
induced nuclear localization of endogenous GR in p23-/- MPKs, the cells were treated with 100
nM Dex for 3 hours and, as expected, the majority of GR in wild-type cells within this time
accumulated in the nucleus. In contrast, in p23-/- cells, we observed a reduced nuclear localiza-
tion under the same conditions (Fig 5A), confirming our previous results with exogenously
expressed GR [22]. These results are also consistent with our observation that GR target genes
in skin are misregulated (see above). When we analyzed the impact of Dex on the proliferation
of MPKs, the effects of the addition of the synthetic glucocorticoid dexamethasone (Dex)
turned out to depend on the genotype. At 120 h after seeding in the presence of Dex, the num-
ber of wild-type MPKs was reduced whereas Dex had a modest growth stimulatory effect on
p23-/- MPKs (Fig 5B). It is conceivable that the effects on proliferation are due to the direct or
indirect dysregulation of certain genes as suggested by the data shown in Fig 2B and 2C.
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In contrast to these results indicating defects in GR maturation and signaling, we found
that the Dex-stimulated differentiation is not impaired, at least not in isolated MPKs. It has
been shown that addition of Dex to wild-type MPKs induces differentiation over time [26];
although we could see morphological changes in response to Dex, there was no obvious differ-
ence between the two genotypes (Fig 6A). Unlike Ca2+, which failed to fully induce differentia-
tion of MPKs devoid of p23 (Fig 4B), Dex was able to induce full differentiation irrespective of
genotype, as judged by immunofluorescence staining for differentiation markers (Fig 6B).
Although a relatively high concentration of Dex (1 μM) was used here, 100 nM gave similar
results (data not shown).
Discussion
In our initial report on the phenotype of the p23 gene disruption, we highlighted the promi-
nent skin phenotype; we speculated based on the resemblance to the phenotype of the GR
knockout and on experiments with mouse embryo fibroblasts that it may, at least in part, be
due to defective GR maturation and signaling [22]. Our characterization had remained incom-
plete and the fact that p23 was missing from all cells did not allow us to conclude that p23 is
required in the skin itself or any particular cell type of the skin. Here we have further character-
ized the skin phenotype, and we could demonstrate with isolated MPKs that some defects are
due to keratinocyte-specific functions of p23.
At the phenotypic level, we confirm the striking resemblance of the p23 gene disruption
mutant with GR knockout mice [25–28]. The epidermis is considerably thinner with an almost
Fig 3. Isolation of primary MPKs. (a) Total number of MPKs that can be obtained from the epidermis of individual p23-/- E18.5
embryos compared to wild-type is significantly lower (* p<0.05; n: WT = 24, p23-/- = 26). (b) Representative micrographs showing
differences in cell confluency after seeding MPKs; bars = 50 μm. (c) Increased growth rate of p23-/- MPKs; * p value at 120 h <0.05 (n:
WT = 3, p23-/- = 3). (d, e) Increased apoptosis of p23-/- compared to wild-type MPKs without (d; **** p<0.0001; n: WT = 10, p23-/- = 6)
and following UV treatment (e; **** p<0.0001; n: WT = 6, p23-/- = 11).
https://doi.org/10.1371/journal.pone.0180035.g003
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absent stratum corneum. There are fewer hair follicles, skin differentiation markers are
reduced, there are more apoptotic cells and signs of hyperproliferation. Apart from the superfi-
cial similarities between p23 and GR mutant embryos, we found that in the absence of p23, GR
target genes are misregulated in embryonic skin, and that glucocorticoid signaling is partially
Fig 4. Differentiation of p23-/- MPKs in vitro is impaired. (a) Undifferentiated wild-type and p23-/- MPKs from E18.5 embryos were
induced to differentiate with 1.2 mM Ca2+ for 24 h and 48 h. No obvious morphological differences were noted by phase contrast
microscopy (bars = 50 μm). (b) Immunofluorescence staining for epithelial markers demonstrates impaired differentiation of p23-/-
MPKs. Note that only a subset of cells are expected to express K-10 at the relatively early 24 h time point. K-10, keratin-10.
https://doi.org/10.1371/journal.pone.0180035.g004
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Fig 5. Dex differentially affects p23-/- versus wild-type MPKs. (a) Nuclear localization of GR is impaired in
p23-/- MPKs. Immunofluorescence micrographs of cells treated with 100 nM Dex for 3 h and stained with an
Skin phenotype of mouse embryos without Hsp90 co-chaperone p23
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defective in isolated embryonic MPKs. GR cannot be fully activated, and the impact of the syn-
thetic glucocorticoid Dex on the proliferation of MPKs is opposite when comparing wild-type
and p23-null MPKs.
Although we may speculate that GR is a major target of the p23 or p23-Hsp90 system in the
skin, we cannot conclude that it is the only one. It is likely that some defects of p23-null skin
relate to GR- and perhaps even Hsp90-independent functions of p23 [42–44]. These have yet
to be characterized and it is impossible to guess which ones may be relevant to the skin pheno-
type reported here. Specifically, we do not yet know whether the increased spontaneous or
UV-stimulated apoptosis and impaired Ca2+-induced differentiation of p23-null MPKs are
linked to a GR defect. In fact, GR-null MPKs differ from p23-null MPKs in that they can be
induced to differentiate properly with Ca2+ [26] suggesting that this response may require a
GR-independent function of p23. Surprisingly, we found that induction of differentiation by
Dex does not appear to be affected by the absence of p23. One complication is that Dex also
activates the mineralocorticoid receptor (MR) albeit with reduced affinity and efficiency [45].
antibody to GR (bars = 50 μm). (b) Opposite effects of 1 μM Dex on the proliferation of wild-type (* p<0.05)
and p23-/- (* p<0.05) MPKs 120 h after seeding (n: WT = 3, p23-/- = 3).
https://doi.org/10.1371/journal.pone.0180035.g005
Fig 6. GR-mediated effects on MPK differentiation are not affected by loss of p23. (a) Phase contrast
micrographs of MPKs induced to differentiate with 1 μM Dex for 48 h. (b) Immunofluorescent staining for the
differentiation markers keratin-10 (K-10), E-cadherin and involucrin in wild-type and p23-/- MPKs treated with
1 μM Dex for 48 h (bars = 50 μm).
https://doi.org/10.1371/journal.pone.0180035.g006
Skin phenotype of mouse embryos without Hsp90 co-chaperone p23
PLOS ONE | https://doi.org/10.1371/journal.pone.0180035 June 26, 2017 10 / 17
MR in the epidermis does play an important role, mediates some glucocorticoid effects and is
required along with GR for proper keratinocyte differentiation [46]. While MR, just like GR, is
itself an Hsp90 client [47], its p23 dependence is less well understood. Overexpression of p23
has been reported to have opposite effects on GR and MR transcriptional activities in both
mammalian cells and yeast, stimulating GR and inhibiting MR [16]. More recently, a differen-
tial requirement for Hsp90 itself was suggested by the finding that HDAC6-reversible Hsp90
acetylation affects the interaction of Hsp90 with MR and the subcellular localization of apo-
MR, but not its transcriptional response whereas GR activity is severely compromised [48].
How this relates to the ability of p23 to promote the transfer of immature GR from Hsp70 to
Hsp90 in vitro [49], and whether MR would behave differently, is not known. Clearly, further
investigations will be necessary to dissect the relative contributions of GR and MR to skin
development and differentiation, and to understand their relative dependence on the Hsp90
molecular chaperone machine in general, and on p23 in particular. Interpreting the p23 skin
phenotype in terms of an Hsp90 defect is not straightforward either. The Hsp90β gene knock-
out is an early embryonic lethal [50] and the Hsp90α gene knockout, albeit viable, does not
lead to any obvious skin phenotype [51]. Secreted Hsp90α plays an important role in skin
wound healing as a response to hypoxia [52–54], but p23 is not thought to be associated with
secreted Hsp90.
We see keratinocyte-autonomous defects in the absence of p23, but we cannot exclude that
the loss of p23 functions in other cell types of the epidermis or even in deeper layers of the skin
contribute to the skin phenotype. Similarly, the postnatal functions of p23 in the mouse, in any
tissue, remain unknown. If GR is indeed one of the key targets of p23, one could postulate that
p23 plays a variety of postnatal functions beyond the skin, as does GR [55]. Our efforts to
develop a conditionally mutated p23 allele have not yet been successful. However, this is defi-
nitely the way to go to explore the p23-GR connection in more detail and to uncover addi-
tional functions of p23 that may in many cases be overshadowed by the flailing GR.
Although not much is known about the regulation of p23 expression and protein stability,
there are some precedents that are worth mentioning. Apoptotic stimuli and stress of the
endoplasmic reticulum can lead to the caspase-mediated cleavage of p23 [37,38,56]. p23 levels
may be upregulated in certain types of cancer [57,58] and by ischemia [59], and downregulated
in atherosclerotic plaques [60]. Thus, it is conceivable that certain physiological or pathological
influences could modulate p23 levels and thereby affect skin integrity even in the adult.
Materials and methods
p23 mutant mouse strain and processing of embryos
The p23 mutant mouse strain and the PCR-based genotyping with DNA isolated from mouse
tail biopsies have previously been described; all of the work described here was performed with
mouse line A [22], generated from a gene trap insertion into the p23 gene Ptges3 of clone
W069F07 (see http://www.genetrap.org). Mice were maintained as heterozygotes and housed
in standard conditions. E18.5 embryos were collected at 18.5 d after conception. Dorsal skin
excised from E18.5 embryos was either rapidly frozen in liquid nitrogen for protein isolation,
fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) for histological analyses or
immunohistochemistry, or processed for preparation of MPKs as described below. Animals to
be sacrificed were euthanized in a chamber with carbon dioxide. Animal research was done
according to Swiss law and with approval of local (the "Commission cantonale pour les expe´ri-
ences sur animaux" and the "Office ve´te´rinaire cantonal") and federal authorities ("Office ve´te´r-
inaire fe´de´ral").
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Histology and immunohistochemistry
E18.5 dorsal skin samples destined for histological analyses were processed, paraffin embedded
and sectioned prior to H&E or immunohistochemical staining according to standard proto-
cols. Primary antibodies against p23, filagrin and involucrin were diluted 1:1’000, the one
against GR 1:100, for Fkbp51 1:400, and for loricrin 1:2’000; secondary antibodies were diluted
1:2’000.
Morphometric analyses: Epidermal thickness and hair follicle number
Representative pictures of H&E stained skin sections were randomly chosen and the epidermal
width or number of hair follicles within five individual fields of view was calculated for each
section using the software ImageJ. Experiments were performed in at least three individuals of
each genotype.
TUNEL staining
In order to identify apoptotic cells in skin sections DeadEnd Fluorometric TUNEL System
(Promega) was used according to manufacturer’s instructions. Experiments were performed
with at least three individuals of each genotype.
In vivo epidermal BrdU staining
Intraperitoneal injection of BrdU at 130 μg/g of mouse body weight (Roche) was done 1 h
before sacrifice in order to detect epithelial cell proliferation. To determine BrdU incorpo-
ration immunohistochemistry of paraffin-embedded skin sections using a mouse anti-BrdU
monoclonal antibody (Roche) was performed. Total number of cells along with BrdU-positive
cells was counted per 200 μm of interfollicular epithelium in each section. Experiments were
performed with at least three individuals of each genotype.
Antibodies
Antibodies against keratin-10 (K-10; PRB-159P; Covance), E-cadherin (H-108; Santa
Cruz), involucrin (SY5; Abcam), GR (M-20 or H-300; Santa Cruz Biotechnology), p23 (JJ3;
a gift from David O. Toft, Mayo Clinic), Fkbp51 (HI51B; a gift from Marc Cox, University
of Texas at El Paso), loricrin, (PRB-145P; Covance), filaggrin (PRB-417P; Covance) and
GAPDH (Abcam) were used for immunohistochemistry, immunofluorescence or immu-
noblotting. Secondary biotin-conjugated (Vector Laboratories), peroxidase-conjugated
(DAKO) or FITC- or Texas Red- (Vector Laboratories) conjugated anti-rabbit or anti-
mouse antibodies were used for immunohistochemistry, immunoblotting or immunofluo-
rescence, respectively.
Immunoblotting
Protein extracts from the epidermis of E18.5 embryos were prepared according to standard
protocol. Equal amounts of protein extracts were subjected to SDS-PAGE and followed by
standard immunoblotting procedures. Dilutions of primary antibodies against p23, GR,
Fkbp51, and GAPDH were 1:1’000, 1:500, 1:1’000, and 1:10’000, respectively. Experiments
were performed with samples from at least three individuals of each genotype. Quantification
of protein levels was done using ImageJ software.
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Harvesting of MPKs
Embryos were placed in betadine (Mundipharma), 70% ethanol, no calcium Dulbecco’s PBS
without calcium (DPBS) (from Gibco), 70% ethanol and DPBS for 5 min each. The tail of each
embryo was then collected for genotyping, the limbs and snout were cut off and an incision
was made from the posterior part of the back up to the snout before the skin was carefully
peeled off and washed in DPBS. Skins were placed epidermal side up in dispase II (3 U/ml in
medium; Roche) in separate 35 mm culture dishes and incubated overnight at 4˚C. Epidermis
was then separated from the dermis with forceps and placed in new dishes containing 1 ml of
accutase (CELLnTEC) for 20 min at room temperature. Afterwards 2 ml of low calcium CnT-
07 Epidermal Keratinocyte medium (CELLnTEC) and 2 ml of DPBS was added to each dish
and repeated pipetting was used to dissociate keratinocytes from the epidermal sheet. Dissoci-
ated cells were then collected, centrifuged for 5 min at 1000 rpm and resuspended in 1 ml of
CnT-07 medium. The number of cells obtained from each embryo was calculated using hae-
mocytometer and a specific number of cells was seeded in culture dishes coated with collagen I
(Sigma) and immediately used for experiments as indicated. MPKs were cultured in CnT-07
medium at 37˚C.
MPK treatments
To induce keratinocyte differentiation, MPKs were grown until confluency in CnT-07 low cal-
cium medium and then 1.2 mM Ca2+ was added for either 24 h or 48 h. Prior to addition of
1 μM Dex or vehicle (ethanol), confluent MPKs were incubated overnight in charcoal-stripped
low calcium medium (DMEM without phenol red from Gibco with 4% serum depleted of ste-
roids with charcoal, supplemented with 0.05 mM Ca2+ ["low calcium"], 10 ng/ml EGF and
antibiotics). Dex was added either at 100 nM for 3 h to induce the nuclear localization of GR
or at 1 μM to monitor the effects on proliferation and for 48 h to induce keratinocyte
differentiation.
Immunofluorescence staining
Cells were grown on glass coverslips in 12- or 24-well plates and fixed with methanol:acetone
(70:30, v/v). The air-dried coverslips were stored at -20˚C until needed or used immediately
for immunofluorescence staining. Staining was done by incubation with the primary and sec-
ondary antibodies in 1% BSA for 2 h each. Dilutions of primary antibodies against GR, K-10,
E-cadherin, and involucrin were 1:200. Coverslips were mounted with DAPI-containing Vec-
tashield mounting medium (Vector Laboratories).
Annexin V staining
Where indicated, 35 mm culture dishes with confluent MPKs were subjected ultraviolet irradi-
ation at 150 mJcm−2 using the UV Stratalinker 1800 (Stratagene), and incubated in fresh
medium for 6 h at 37˚C. Cells were detached using 0.25% Trypsin-EDTA (Gibco), collected by
centrifugation, washed twice in cold PBS and resuspended in 500 μl of 1x binding buffer (0.1
M Hepes pH 7.4, 1.4 M NaCl, 25 mM CaCl2). 100 μl of the cell-containing binding buffer solu-
tion was transferred to a 5 ml FACS tube, 5 μl of FITC Annexin V (BD Biosciences) and 10 μl
of propidium iodide (PI) (50 μg/ml; Invitrogen) were added, cells were gently shaken and
incubated for 15 min at room temperature in the dark. Annexin V and PI binding was ana-
lyzed by flow cytometry using a BD FACSCanto instrument with the BD CellQuestPro soft-
ware (BD Biosciences). FITC signal detector (FL1) and PI signal detector (FL3) were used to
distinguish between apoptotic and live cells. At least 10’000 events were counted per run.
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MTT cell proliferation assay
MPKs were plated at equal densities in a 96-well plate and their proliferation was monitored
by performing MTT assays with 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (Applichem).
Quantitative real-time PCR
Total RNA was isolated from E18.5 epidermis using guanidinium-acid-phenol as previously
described [61]. 1 μg of total RNA was reverse transcribed using random primers (hexadeoxy-
nucleotide mix, Promega) with the GoScript reverse transcriptase (Promega) as indicated by
the manufacturer. Expression of GR target genes in the epidermis and of the internal standard
GAPDH using specific primers was then analyzed by quantitative real-time PCR with the
GoTaq Green Master Mix (Promega) according to the manufacturer’s instructions. The for-
ward and reverse primers for Krt77 were CCAGGTGCTACAGACAAAATGG and GCTGACTGA
TGAACTCCTCGAA, for Elf5, ACCGATCTGTTCAGCAATGAAGand CGCTTGGTCCAGTATTC
AGG, for Cdsn, TTGCTGATGGCCGGTCTTATT and GCCAGTCTTTCCAATGAGACAAG, for
Defb1, CCTCATCTGTCAGCCCAACTand GTGAGAATGCCAACACCTGG, and for Gapdh, GCAC
AACAGGAAGAGAGAGACCand AGGGGAGATTCAGTGTGGTG.
Statistical analyses
GraphPad Prism (GraphPad Software) was used for statistical analyses. Results were subjected
to Student’s t-test analysis. Graphs represent arithmetic means ± standard error of the mean
(SEM). Differences with P values of P<0.05 were considered to be statistically significant.
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